MedinCell Publishes Its Financial Results for the First Seme

Regulatory News: MedinCell (Paris:MEDCL): Revenue: €7.7 million (+89% compared to the first half of the previous year) Operating expenses: €19.4 million (+27% compared to the first half of

Related Keywords

United States , San Antonio , Texas , France , Jaime Arango , Richard Malamut , Nicolas Merigeau , Louis Victor Delouvrier Alban Dufumier , David Heuz , Arthristis Innovation Corporation , Head Of Communications , Medincell Program , Drug Administration , Melinda Gates Foundation , Company Supervisory Board , Global Health , Research Tax Credit , Teva At Psych Congress , European Investment Bank , Regulatory News , Chief Financial Officer , Complete Response Letter , Bill Melinda Gates Foundation , Psych Congress , Cell Program , Research Tax , Medical Director , Medical Board , Executive Board , Des March , Medincell , Ublishes , Financial , Results , First , Semester , 022 , 023 , Pril , September ,